Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer (Adv. Therap. 3/2023)
Receptor‐mediated endocytosis of a precision engineered HER2‐targeting ultrasmall silica nanoparticle drug conjugate after binding the HER2 extracellular domain on gastric cancer cells. This is reported by Ulrich Wiesner, J. Anand Subramony, Michelle S. Bradbury, and co‐workers in article number 220...
Gespeichert in:
| Veröffentlicht in: | Advanced therapeutics 2023-03, Vol.6 (3), p.n/a |
|---|---|
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | n/a |
|---|---|
| container_issue | 3 |
| container_start_page | |
| container_title | Advanced therapeutics |
| container_volume | 6 |
| creator | Zhang, Li Aragon‐Sanabria, Virginia Aditya, Anusha Marelli, Marcello Cao, Tianye Chen, Feng Yoo, Barney Ma, Kai Zhuang, Li Cailleau, Thais Masterson, Luke Turker, Melik Z. Lee, Rachel DeLeon, Gabriel Monette, Sebastien Colombo, Raffaele Christie, Ronald J. Zanzonico, Pat Wiesner, Ulrich Subramony, J. Anand Bradbury, Michelle S. |
| description | Receptor‐mediated endocytosis of a precision engineered HER2‐targeting ultrasmall silica nanoparticle drug conjugate after binding the HER2 extracellular domain on gastric cancer cells. This is reported by Ulrich Wiesner, J. Anand Subramony, Michelle S. Bradbury, and co‐workers in article number 2200209. |
| doi_str_mv | 10.1002/adtp.202370009 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10061546</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2794694338</sourcerecordid><originalsourceid>FETCH-LOGICAL-c2419-54dbab1491790814e23dd0c746a92773fa2b1bbb113ac303c346bbd4be100b403</originalsourceid><addsrcrecordid>eNqFkc1uEzEYRUcIRKvSLUvkZVlk6r8ZZ1YoSkJbqQKE0rXlny-JK48n2DOpsssjILGlL5cn6UQpoaxY2ZLPPfbnm2XvCc4JxvRS2XaVU0yZwBhXr7JTyspywKqheP1if5Kdp3TfExQTJoribXayD4hiKE6zX9OwcAEggkV3vo0q1cp79EWFZqVi64wHNIndYrf9eVPXXQA0bsJ9t1AtJPTg2iXabX9fuxapYNH3Luy2j2jW1U1EE_BuDXGD2gZNo7LO9Bl0pVIbnUFjFQxEdDGy6xzNlhDVKkfscj_Mx3fZm7nyCc6f17Ps7vN0Nr4e3H69uhmPbgeGclINCm610oRXRFR4SDhQZi02gpeqokKwuaKaaK0JYcowzAzjpdaWa-g_T3PMzrJPB--q0zVYA6Gf38tVdLWKG9koJ_89CW4pF81a9vmSFLzsDRfPhtj86CC1snbJgPcqQNMlSUXFy4ozNuzR_ICa2KQUYX68h-C9kMp9m_LYZh_48PJ1R_xPdz1QHYAH52HzH50cTWbf_sqfAGYnr2A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2794694338</pqid></control><display><type>article</type><title>Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer (Adv. Therap. 3/2023)</title><source>Wiley Online Library Journals Frontfile Complete</source><creator>Zhang, Li ; Aragon‐Sanabria, Virginia ; Aditya, Anusha ; Marelli, Marcello ; Cao, Tianye ; Chen, Feng ; Yoo, Barney ; Ma, Kai ; Zhuang, Li ; Cailleau, Thais ; Masterson, Luke ; Turker, Melik Z. ; Lee, Rachel ; DeLeon, Gabriel ; Monette, Sebastien ; Colombo, Raffaele ; Christie, Ronald J. ; Zanzonico, Pat ; Wiesner, Ulrich ; Subramony, J. Anand ; Bradbury, Michelle S.</creator><creatorcontrib>Zhang, Li ; Aragon‐Sanabria, Virginia ; Aditya, Anusha ; Marelli, Marcello ; Cao, Tianye ; Chen, Feng ; Yoo, Barney ; Ma, Kai ; Zhuang, Li ; Cailleau, Thais ; Masterson, Luke ; Turker, Melik Z. ; Lee, Rachel ; DeLeon, Gabriel ; Monette, Sebastien ; Colombo, Raffaele ; Christie, Ronald J. ; Zanzonico, Pat ; Wiesner, Ulrich ; Subramony, J. Anand ; Bradbury, Michelle S.</creatorcontrib><description>Receptor‐mediated endocytosis of a precision engineered HER2‐targeting ultrasmall silica nanoparticle drug conjugate after binding the HER2 extracellular domain on gastric cancer cells. This is reported by Ulrich Wiesner, J. Anand Subramony, Michelle S. Bradbury, and co‐workers in article number 2200209.</description><identifier>ISSN: 2366-3987</identifier><identifier>EISSN: 2366-3987</identifier><identifier>DOI: 10.1002/adtp.202370009</identifier><identifier>PMID: 37007587</identifier><language>eng</language><publisher>Germany</publisher><ispartof>Advanced therapeutics, 2023-03, Vol.6 (3), p.n/a</ispartof><rights>2023 Wiley‐VCH GmbH</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fadtp.202370009$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fadtp.202370009$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/37007587$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Zhang, Li</creatorcontrib><creatorcontrib>Aragon‐Sanabria, Virginia</creatorcontrib><creatorcontrib>Aditya, Anusha</creatorcontrib><creatorcontrib>Marelli, Marcello</creatorcontrib><creatorcontrib>Cao, Tianye</creatorcontrib><creatorcontrib>Chen, Feng</creatorcontrib><creatorcontrib>Yoo, Barney</creatorcontrib><creatorcontrib>Ma, Kai</creatorcontrib><creatorcontrib>Zhuang, Li</creatorcontrib><creatorcontrib>Cailleau, Thais</creatorcontrib><creatorcontrib>Masterson, Luke</creatorcontrib><creatorcontrib>Turker, Melik Z.</creatorcontrib><creatorcontrib>Lee, Rachel</creatorcontrib><creatorcontrib>DeLeon, Gabriel</creatorcontrib><creatorcontrib>Monette, Sebastien</creatorcontrib><creatorcontrib>Colombo, Raffaele</creatorcontrib><creatorcontrib>Christie, Ronald J.</creatorcontrib><creatorcontrib>Zanzonico, Pat</creatorcontrib><creatorcontrib>Wiesner, Ulrich</creatorcontrib><creatorcontrib>Subramony, J. Anand</creatorcontrib><creatorcontrib>Bradbury, Michelle S.</creatorcontrib><title>Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer (Adv. Therap. 3/2023)</title><title>Advanced therapeutics</title><addtitle>Adv Ther (Weinh)</addtitle><description>Receptor‐mediated endocytosis of a precision engineered HER2‐targeting ultrasmall silica nanoparticle drug conjugate after binding the HER2 extracellular domain on gastric cancer cells. This is reported by Ulrich Wiesner, J. Anand Subramony, Michelle S. Bradbury, and co‐workers in article number 2200209.</description><issn>2366-3987</issn><issn>2366-3987</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><recordid>eNqFkc1uEzEYRUcIRKvSLUvkZVlk6r8ZZ1YoSkJbqQKE0rXlny-JK48n2DOpsssjILGlL5cn6UQpoaxY2ZLPPfbnm2XvCc4JxvRS2XaVU0yZwBhXr7JTyspywKqheP1if5Kdp3TfExQTJoribXayD4hiKE6zX9OwcAEggkV3vo0q1cp79EWFZqVi64wHNIndYrf9eVPXXQA0bsJ9t1AtJPTg2iXabX9fuxapYNH3Luy2j2jW1U1EE_BuDXGD2gZNo7LO9Bl0pVIbnUFjFQxEdDGy6xzNlhDVKkfscj_Mx3fZm7nyCc6f17Ps7vN0Nr4e3H69uhmPbgeGclINCm610oRXRFR4SDhQZi02gpeqokKwuaKaaK0JYcowzAzjpdaWa-g_T3PMzrJPB--q0zVYA6Gf38tVdLWKG9koJ_89CW4pF81a9vmSFLzsDRfPhtj86CC1snbJgPcqQNMlSUXFy4ozNuzR_ICa2KQUYX68h-C9kMp9m_LYZh_48PJ1R_xPdz1QHYAH52HzH50cTWbf_sqfAGYnr2A</recordid><startdate>202303</startdate><enddate>202303</enddate><creator>Zhang, Li</creator><creator>Aragon‐Sanabria, Virginia</creator><creator>Aditya, Anusha</creator><creator>Marelli, Marcello</creator><creator>Cao, Tianye</creator><creator>Chen, Feng</creator><creator>Yoo, Barney</creator><creator>Ma, Kai</creator><creator>Zhuang, Li</creator><creator>Cailleau, Thais</creator><creator>Masterson, Luke</creator><creator>Turker, Melik Z.</creator><creator>Lee, Rachel</creator><creator>DeLeon, Gabriel</creator><creator>Monette, Sebastien</creator><creator>Colombo, Raffaele</creator><creator>Christie, Ronald J.</creator><creator>Zanzonico, Pat</creator><creator>Wiesner, Ulrich</creator><creator>Subramony, J. Anand</creator><creator>Bradbury, Michelle S.</creator><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>202303</creationdate><title>Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer (Adv. Therap. 3/2023)</title><author>Zhang, Li ; Aragon‐Sanabria, Virginia ; Aditya, Anusha ; Marelli, Marcello ; Cao, Tianye ; Chen, Feng ; Yoo, Barney ; Ma, Kai ; Zhuang, Li ; Cailleau, Thais ; Masterson, Luke ; Turker, Melik Z. ; Lee, Rachel ; DeLeon, Gabriel ; Monette, Sebastien ; Colombo, Raffaele ; Christie, Ronald J. ; Zanzonico, Pat ; Wiesner, Ulrich ; Subramony, J. Anand ; Bradbury, Michelle S.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c2419-54dbab1491790814e23dd0c746a92773fa2b1bbb113ac303c346bbd4be100b403</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Zhang, Li</creatorcontrib><creatorcontrib>Aragon‐Sanabria, Virginia</creatorcontrib><creatorcontrib>Aditya, Anusha</creatorcontrib><creatorcontrib>Marelli, Marcello</creatorcontrib><creatorcontrib>Cao, Tianye</creatorcontrib><creatorcontrib>Chen, Feng</creatorcontrib><creatorcontrib>Yoo, Barney</creatorcontrib><creatorcontrib>Ma, Kai</creatorcontrib><creatorcontrib>Zhuang, Li</creatorcontrib><creatorcontrib>Cailleau, Thais</creatorcontrib><creatorcontrib>Masterson, Luke</creatorcontrib><creatorcontrib>Turker, Melik Z.</creatorcontrib><creatorcontrib>Lee, Rachel</creatorcontrib><creatorcontrib>DeLeon, Gabriel</creatorcontrib><creatorcontrib>Monette, Sebastien</creatorcontrib><creatorcontrib>Colombo, Raffaele</creatorcontrib><creatorcontrib>Christie, Ronald J.</creatorcontrib><creatorcontrib>Zanzonico, Pat</creatorcontrib><creatorcontrib>Wiesner, Ulrich</creatorcontrib><creatorcontrib>Subramony, J. Anand</creatorcontrib><creatorcontrib>Bradbury, Michelle S.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Advanced therapeutics</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Zhang, Li</au><au>Aragon‐Sanabria, Virginia</au><au>Aditya, Anusha</au><au>Marelli, Marcello</au><au>Cao, Tianye</au><au>Chen, Feng</au><au>Yoo, Barney</au><au>Ma, Kai</au><au>Zhuang, Li</au><au>Cailleau, Thais</au><au>Masterson, Luke</au><au>Turker, Melik Z.</au><au>Lee, Rachel</au><au>DeLeon, Gabriel</au><au>Monette, Sebastien</au><au>Colombo, Raffaele</au><au>Christie, Ronald J.</au><au>Zanzonico, Pat</au><au>Wiesner, Ulrich</au><au>Subramony, J. Anand</au><au>Bradbury, Michelle S.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer (Adv. Therap. 3/2023)</atitle><jtitle>Advanced therapeutics</jtitle><addtitle>Adv Ther (Weinh)</addtitle><date>2023-03</date><risdate>2023</risdate><volume>6</volume><issue>3</issue><epage>n/a</epage><issn>2366-3987</issn><eissn>2366-3987</eissn><abstract>Receptor‐mediated endocytosis of a precision engineered HER2‐targeting ultrasmall silica nanoparticle drug conjugate after binding the HER2 extracellular domain on gastric cancer cells. This is reported by Ulrich Wiesner, J. Anand Subramony, Michelle S. Bradbury, and co‐workers in article number 2200209.</abstract><cop>Germany</cop><pmid>37007587</pmid><doi>10.1002/adtp.202370009</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 2366-3987 |
| ispartof | Advanced therapeutics, 2023-03, Vol.6 (3), p.n/a |
| issn | 2366-3987 2366-3987 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_10061546 |
| source | Wiley Online Library Journals Frontfile Complete |
| title | Engineered Ultrasmall Nanoparticle Drug‐Immune Conjugates with “Hit and Run” Tumor Delivery to Eradicate Gastric Cancer (Adv. Therap. 3/2023) |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-11T00%3A20%3A20IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Engineered%20Ultrasmall%20Nanoparticle%20Drug%E2%80%90Immune%20Conjugates%20with%20%E2%80%9CHit%20and%20Run%E2%80%9D%20Tumor%20Delivery%20to%20Eradicate%20Gastric%20Cancer%20(Adv.%20Therap.%203/2023)&rft.jtitle=Advanced%20therapeutics&rft.au=Zhang,%20Li&rft.date=2023-03&rft.volume=6&rft.issue=3&rft.epage=n/a&rft.issn=2366-3987&rft.eissn=2366-3987&rft_id=info:doi/10.1002/adtp.202370009&rft_dat=%3Cproquest_pubme%3E2794694338%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2794694338&rft_id=info:pmid/37007587&rfr_iscdi=true |